PSNL CLUSTER SEC Filing Analysis

Latest settled — T+5d ⚠ clustered

PSNL ▼ -4.53% at T+5d

SHORT call ✓ call won +4.53% · α vs SPY +1.78% · entry $11.26 → $10.75

Next anchor: T+20d in 14d

Last close $9.59 (close Jun 12) · +14.83% from $11.26 entry (call sign-flipped)

Entry anchored
May 29, 2026
via day open

T+1d

-1.07%

call +1.07% · α +1.21%

$11.14

settled 14d ago

T+5d

-4.53%

call +4.53% · α +1.78%

$10.75

settled 10d ago

T+20d

—

call — · α —

—

in 14d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

CEO Christopher Hall and CFO/COO Aaron Tachibana sold a combined $1.33M in open-market sales on May 28-29, 2026, following derivative exercises at low strike prices. The sales represent ~0.12% of PSNL's $1.1B market cap — modest in proportion — but the cluster of both top executives selling simultaneously warrants attention, especially given the stock's recent strength and the company's 85% bullish analyst consensus.

Key Financial Metrics

Direction

selling

Total Value

$1.3M

Insiders

2

Actionable Insight

The simultaneous CEO and CFO sales after option exercises are a cautionary signal, though the dollar amount is modest relative to market cap. Monitor for any upcoming 8-K or earnings pre-announcement — insider clusters often precede material news. The stock's 85% bullish analyst consensus creates potential downside risk if fundamentals disappoint.

Key Facts

CEO Hall sold 100,000 shares total ($1.1M) on May 28-29 after exercising options at $0 and $1.61 strikes
CFO/COO Tachibana sold 38,799 shares ($449K) on May 29 after exercising options at $0 and $9.16 strikes
Total open-market sales: $1.33M, representing ~0.12% of PSNL's $1.1B market cap
Both executives exercised and sold in the same pattern — derivative exercise followed by immediate open-market sale
No open-market purchases were reported in the cluster

Financial Impact

Insider sales of $1.33M represent 0.12% of market cap — modest but notable as a C-suite cluster

insider ownershipdilution

Risk Factors

C-suite cluster selling may indicate management's view that the stock is fully valued or that near-term headwinds exist
The stock has strong bullish analyst consensus (85% buy) — insider selling could signal a disconnect between street optimism and management's internal outlook
Historical calibration shows prior PSNL reports underperformed by -10.33% at T+20, suggesting the stock may be prone to negative surprises

Market Snapshot

Exchange

Nasdaq

Sector

Services-Medical Laboratories

Analyst Consensus

85% bullish (13 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

Document	Accession Number
CLUSTER Data (Synthetic)	cluster-PSNL-1780101930950

5 reports for PSNL

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for PSNL — sortable, filterable
	Type				Now
Jun 6, 2026 9d ago	Insider Cluster NEUTRAL ★ 3/10	$11.75 awaiting T+5	awaiting T+5	—	$9.59 (−18.38%)
Jun 4, 2026 10d ago	144 NEUTRAL ★ 3/10	$12.08 awaiting T+5	awaiting T+5	—	$9.59 (−20.61%)
May 30, 2026 16d ago	Insider Cluster BEARISH ★ 5/10	$11.26 $10.75	▲ +4.53%	▲ +1.78%	$9.59 (+14.83%)
May 29, 2026 16d ago	144 NEUTRAL ★ 3/10	$11.26 $10.75	▼ −4.53%	▼ −1.78%	$9.59 (−14.83%)
May 28, 2026 17d ago	144 BEARISH ★ 5/10	$11.40 $10.75	▲ +5.70%	▲ +3.18%	$9.59 (+15.88%)

US Market Status

Market Closed — Opens in 1h 41m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access